Anterogen.Co.,Ltd. (KOSDAQ:065660)

Revance Therapeutics Revenue

Anterogen.Co.,Ltd. had revenue of 1.60B KRW in the quarter ending March 31, 2025, with 4.56% growth. This brings the company's revenue in the last twelve months to 7.00B, up 7.90% year-over-year. In the year 2024, Anterogen.Co.,Ltd. had annual revenue of 6.93B with 6.66% growth.

• Revenue (ttm): 7.00B
• Revenue Growth: +7.90%
• P/S Ratio: 36.29
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 254.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.93B	432.62M	6.66%
Dec 31, 2023	6.50B	-90.76M	-1.38%
Dec 31, 2022	6.59B	-1.53B	-18.85%
Dec 31, 2021	8.12B	3.97B	95.64%
Dec 31, 2020	4.15B	3.67M	0.09%